Inspire Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for Inspire Medical Systems (INSP).

Price Target Range — 9 Quarters

Analyst Consensus — 16 Analysts

6Buy

8Hold

2Sell

Consensus RatingNeutral# Analysts16Avg. Consensus PT$85Upside to Avg. PT+19.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$62→$78
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Underweight	$65
Oct 2, 2026	Freedom Capital Markets	Keith Hinton	Maintained	Buy	$97
Oct 1, 2026	RBC Capital	Kendall Au	PT Raise	Sector Perform	$60→$75
Sep 21, 2026	Freedom Capital Markets	Keith Hinton	PT Raise	Buy	$71→$97
Sep 11, 2026	Stifel	Jonathan Block	PT Raise	Buy	$75→$80
Aug 4, 2026	JP Morgan	Robbie Marcus	PT Raise	Neutral	$54→$60
Aug 4, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$55→$65
Aug 4, 2026	Oppenheimer	Suraj Kalia	Upgrade	Perform→Outperform	$85
Aug 4, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$54→$62
Aug 4, 2026	Piper Sandler	Adam Maeder	PT Raise	Neutral	$55→$60
Aug 4, 2026	Evercore ISI Group	Daniel Markowitz	PT Raise	In-Line	$40→$54
Aug 4, 2026	Baird	Mike Polark	PT Raise	Neutral	$54→$59
Jul 28, 2026	UBS	Patrick Wood	Assumes	Neutral→Sell	$67→$39
Jul 16, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$50→$54
Jul 1, 2026	Freedom Capital Markets	Keith Hinton	Initiate	Buy	$62
Jun 23, 2026	Evercore ISI Group	Daniel Markowitz	Downgrade	Outperform→In-Line	$55→$40
May 7, 2026	Oppenheimer	Suraj Kalia	Maintained	Perform	—
May 5, 2026	JP Morgan	Robbie Marcus	PT Cut	Neutral	$67→$54
May 5, 2026	Piper Sandler	Adam Maeder	Downgrade	Overweight→Neutral	$85→$55

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78

Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $62 to $78.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

Barclays analyst Christopher Pasquale initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Underweight rating and announces Price Target of $65.

Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75

RBC Capital analyst Kendall Au maintains Inspire Medical Systems (NYSE:INSP) with a Sector Perform and raises the price target from $60 to $75.

Benzinga Newsdesk

PRO
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $75 to $80.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.

Benzinga Newsdesk

Inspire Medical Systems Inc

Inspire Medical Systems Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78

PRO
Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

PRO
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75

PRO
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

PRO
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

People Also Watch

People Also Watch

Inspire Medical Systems Inc

Inspire Medical Systems Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78

PROBarclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

PRORBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75

PROFreedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

PROStifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

PROJP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78

PRO
Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

PRO
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75

PRO
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

PRO
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60